Insights On Drug Development
-
Deciphering Nanoparticle Properties With AF4
5/6/2026
Discover how risk‑based, phase‑appropriate synthesis enables safe, efficient production of highly potent compounds while balancing speed, worker safety, and regulatory readiness in early development.
-
Drug Substance For Early Clinical Phase Initiation
5/6/2026
Explore how proactive nitrosamine impurity risk assessment protects early clinical drug supply, minimizes development delays, and enables confident progression to first‑in‑human studies.
-
Accelerating Drug Development: Solid State Chemistry And Strategic Outsourcing
5/6/2026
Discover how phase‑appropriate solid‑state chemistry and strategic outsourcing reduce risk, speed development timelines, and enable confident solid‑form selection for complex small‑molecule programs.
-
A Simple And Powerful Solution For Accelerating Dissolution
5/5/2026
Many poorly soluble drugs fail not because of low solubility, but because they dissolve too slowly. Learn how focusing on dissolution rate can unlock absorption gains using simple strategies.
-
Advancing Cell Culture Strategies To Accelerate Biologics Development
5/5/2026
Integrated stable expression strategies accelerate biologics material generation, improving scalability, consistency, and early developability insights while reducing bottlenecks, variability, and risks in transitioning from discovery to manufacturing.
-
Spray Dried Biologics For Injectable Dosage Forms
5/1/2026
Experts highlight spray drying as a gentle, scalable way to stabilize biologics, supporting high‑concentration injectables with controlled particles, sterility, and flexible delivery.
-
Formulation & Delivery Of Spray Dried Biologics For Nasal Dosage Forms
4/27/2026
Spray drying enables stable, scalable dry‑powder nasal biologics, improving shelf life, particle control, and targeted delivery for peptides, proteins, vaccines, and oligonucleotides.
-
Unlocking The Next Wave Of Cancer Vaccines
4/21/2026
Discover how advanced ionizable LNP formulations and scalable manufacturing strategies can accelerate the development and clinical translation of personalized cancer vaccines.
-
History Of Peptides In Medicine: From Early Chemistry To The GLP-1 Era
4/21/2026
Peptide therapeutics from early chemical breakthroughs to today’s metabolic drugs, highlighting scientific, clinical, and manufacturing advances shaping modern drug development.
-
IP Considerations In Drug Development For Biotech Companies
4/20/2026
Integrate a strategic intellectual property approach early in drug development to streamline research, uncover opportunities, and maximize the return on your investment.